Cromos Pharma explains new EU Medical Device Regulation
Cromos Pharma explains new EU Medical Device Regulation The EU Medical Device Regulation (Regulation (EU) 2017/745) came into effect on 26 May 2021, following a four-year transition period. From this date manufacturers must comply with the new regulation when bringing new medical devices to market. The legislation aims to improve the safety of medical devices in the EU. A growing market for medical
World Hepatitis Day and the role of clinical research
World Hepatitis Day and the role of clinical research Hepatitis is an inflammation of the liver, most commonly caused by viral infection. One of the world’s leading causes of death, viral hepatitis kills as many people worldwide as HIV/AIDS, malaria or tuberculosis. In 2019, WHO estimated that hepatitis B and C caused the deaths of 1.3 million people. Ahead of World Hepatitis Day on July 28,
Decentralized Clinical Trials: Are they here to stay?
Decentralized Clinical Trials: Are they here to stay? Decentralized clinical trials (DCTs) have been central to the continuation of vital clinical studies throughout the COVID-19 pandemic. Previously the uptake of decentralized models has been slow, but the pandemic changed this. There is now consensus among industry leaders that DCTs are here to stay and may have a central role in advancing research especially

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM